David K. King

977 total citations
7 papers, 711 citations indexed

About

David K. King is a scholar working on Surgery, Pharmacology and Oncology. According to data from OpenAlex, David K. King has authored 7 papers receiving a total of 711 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Surgery, 2 papers in Pharmacology and 2 papers in Oncology. Recurrent topics in David K. King's work include Nausea and vomiting management (2 papers), Amino Acid Enzymes and Metabolism (1 paper) and COVID-19 and Mental Health (1 paper). David K. King is often cited by papers focused on Nausea and vomiting management (2 papers), Amino Acid Enzymes and Metabolism (1 paper) and COVID-19 and Mental Health (1 paper). David K. King collaborates with scholars based in United States and Nepal. David K. King's co-authors include Marc D. Wooten, Gary R. Morrow, Joseph A. Roscoe, James N. Atkins, Tom R. Fitch, Jane T. Hickok, Paul Andrews, Jeffrey J. Kirshner, Harry E. Hynes and Richard F. Raubertas and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Preventive Medicine.

In The Last Decade

David K. King

6 papers receiving 683 citations

Peers

David K. King

SURGE

ONCOL

CR

EDM

PRM

P. T. Pullan Australia

Patricia Brophy United States

Anders Sundín Sweden

Marianne Klose Denmark

Peter Bushunow United States

Osvaldo Mazza Argentina

Wojciech Jeske Poland

Volha V. Zhukouskaya Italy

Archna Bajaj United States

Thomas Guttuso United States

P. T. Pullan Australia

David K. King

188 ×0.5

SURGE

68 ×0.3

ONCOL

74 ×0.4

CR

377 ×2.8

EDM

65 ×0.5

PRM

Citations per year, relative to David K. King David K. King (= 1×) peers P. T. Pullan

Countries citing papers authored by David K. King

Since Specialization

Citations

This map shows the geographic impact of David K. King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David K. King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David K. King more than expected).

Fields of papers citing papers by David K. King

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David K. King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David K. King. The network helps show where David K. King may publish in the future.

Co-authorship network of co-authors of David K. King

This figure shows the co-authorship network connecting the top 25 collaborators of David K. King. A scholar is included among the top collaborators of David K. King based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David K. King. David K. King is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Miller, Maureen J., Sharoda Dasgupta, David K. King, et al.. (2021). Severe Acute Respiratory Syndrome Coronavirus 2 Testing Trends Among Persons Aged <18 Years in an Outpatient Pediatric Practice — Metropolitan Atlanta, Georgia, May–December 2020. Journal of Adolescent Health. 69(1). 144–148.

2.

Roscoe, Joseph A., Pascal Jean‐Pierre, Gary R. Morrow, et al.. (2006). Exploratory analysis of the usefulness of acupressure bands when severe chemotherapy-related nausea is expected.. PubMed. 4(1). 16–20. 15 indexed citations

3.

Wilding, George, David K. King, Kendra D. Tutsch, et al.. (2004). Phase I Trial of the Polyamine Analog N1,N14-Diethylhomospermine (DEHSPM) in Patients with Advanced Solid Tumors. Investigational New Drugs. 22(2). 131–138. 11 indexed citations

4.

Morrow, Gary R., Jane T. Hickok, Joseph A. Roscoe, et al.. (2003). Differential Effects of Paroxetine on Fatigue and Depression: A Randomized, Double-Blind Trial From the University of Rochester Cancer Center Community Clinical Oncology Program. Journal of Clinical Oncology. 21(24). 4635–4641. 229 indexed citations

5.

Roscoe, Joseph A., et al.. (2003). Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5‐hydroxytryptamine‐3 antiemetics. Cancer. 97(11). 2880–2886. 171 indexed citations

6.

Strickland, C. June, Polly Feigl, David K. King, et al.. (1997). Improving Breast Self-Examination Compliance: A Southwest Oncology Group Randomized Trial of Three Interventions. Preventive Medicine. 26(3). 320–332. 24 indexed citations

7.

Wooten, Marc D. & David K. King. (1993). Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature. Cancer. 72(11). 3145–3155. 261 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact